Volver a Agenda
Session Chair(s)
Jeff Heilbraun, MS
Vice President, Medical and Scientific Affairs, Cardiology
Clario, United States
Learning Objective : Describe the impact blood pressure (BP) has in the cardiac safety endpoint in clinical R&D trial design; Discuss current challenges in monitoring BP through the different indications and in the different trial phases; Recognize the regulatory considerations in trial design.
Speaker(s)
Panelist
Mary Jane Geiger
ICON, United States
Vice President and TA Lead, Drug Development Services
¿Tiene una cuenta?